Deals
‘Miracle Mushrooms’ Maker Explores Sale That Could Value It at $1 Billion
- Producer of lingzhi mushroom products weighs potential deal
- Owners including private equity firm KV Asia also mulling IPO
Lingzhi mushrooms.
Photographer: Daniel Karmann/picture alliance via Getty Images
This article is for subscribers only.
DXN Holdings Bhd.’s owners are exploring a sale of the Malaysian health supplement producer, in a deal that could value the firm at as much as $1 billion including debt, people with knowledge of the matter said.
Shareholders of DXN, including Southeast Asian private equity firm KV Asia Capital, are working with an adviser on the potential deal, according to the people. They are also considering an initial public offering of the business, the people said, asking not to be identified because the information is private.